Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |